Background The proportion of patients infected with SARS-CoV-2 that are prescribed
antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance …

The pandemic of coronavirus disease 2019 (COVID‐19) is caused by infection with a novel
coronavirus strain, the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). At …

Background Since its appearance in late 2019, infections caused by severe acute
respiratory syndrome coronavirus 2 have created unprecedented challenges for health …

In this paper, a model is proposed of the pathophysiological processes of COVID-19 starting
from the infection of human type II alveolar epithelial cells (pneumocytes) by SARS-CoV-2 …

Background: Coinfection with bacteria, fungi, and respiratory viruses in SARS-CoV-2 is of
particular importance due to the possibility of increased morbidity and mortality. In this meta …

Abstract Background Hong Kong is a densely populated city with a low incidence and
mortality of coronavirus disease 2019 (COVID-19). The city imposed different levels of social …

Background: This study was conducted to determine the prevalence of headache in
coronavirus disease 2019 (COVID-19) and to assess its association as a predictor for …

Introduction COVID-19 clinical course, effective therapeutic regimen, and poor prognosis
risk factors in pediatric cases are still under investigation and no approved vaccinehas been …

Many individuals infected with the severe acute respiratory syndrome coronavirus-2 (SARS-
CoV-2) develop no or only mild symptoms, but some can go on onto develop a spectrum of …

Background Chemokine levels in severe coronavirus disease 2019 (COVID-19) patients
have been shown to be markedly elevated. But the role of chemokines in mild COVID-19 …